Chemically Diverse Secondary Metabolites from<i> Davidia involucrata</i> (Dove Tree)

Song, Li-Yan; Lin, Ran; Wu, Zu-Jian; Ouyang, Ming-An

doi:https://doi.org/10.1155/2016/9806102

Journal of Chemistry

On this page

Abstract Introduction Conclusions Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2016 | Article ID 9806102 | https://doi.org/10.1155/2016/9806102

Chemically Diverse Secondary Metabolites from Davidia involucrata (Dove Tree)

Li-Yan Song,^1,2Ran Lin,^1,2Zu-Jian Wu,¹and Ming-An Ouyang¹

Academic Editor: Artur M. S. Silva

Received28 Jul 2016

Accepted26 Sept 2016

Published20 Oct 2016

Abstract

Dove tree, Davidia involucrata Baill. which is endemic in western China, is not only one of the best known relict species of the tertiary, but also a famous ornamental plant with dove-shaped flowers. A diverse array of secondary metabolites have been isolated and identified from Davidia involucrata. The 58 structures of the secondary metabolites were presented and classified as triterpenoids, tannins, phenolic compounds, lignans, flavonoids, alkaloids, and sterol. In addition, the biosynthetic route of some triterpenoids was proposed. Moreover, the advances in the discovery of unprecedented compounds and uncovering of notable bioactivities were highlighted in this review.

1. Introduction

Dove tree (Davidia involucrata Baill.), as the sole member of the genera Davidia, is listed as one of the “first-grade” nationally protected plants in China. It is a tertiary paleotropical kingdom relic species rare to China and usually regarded as a “botanic living fossil” [1–3]. Dove tree is not only an endangered and rare relic species, but also famous as an ornamental plant by virtue of the pair of large white bracts that surround the small flowers and create the appearance of doves perching among its branches to give the tree its common name (Figure 1). Its distribution is limited to the subtropical mountains of central to southwestern China. Natural populations are often found in deciduous or evergreen broad-leaf forests at elevations of 700–2400 m [4]. Additionally, as an ornamental plant, Davidia involucrata has been introduced from China to many countries since 1904. The ecological, scientific, and horticultural values of Davidia involucrata have been illustrated and well recognized [5–7].

Davidia, Camptotheca, and Nyssa belong to Cornaceae family, which is distributed in Asia and North America. In 1966, Wall et al. discovered camptothecin, a cytotoxic quinoline alkaloid which inhibits the DNA enzyme topoisomerase I (topo I), from the bark and stem of Camptotheca acuminata (Camptotheca, tree of joy) [8]. Encouraged by the potent antitumor agent secured from the plants under Cornaceae family, the phytochemical community have published a number of reports since then and addressed the structures and biological activities of chemical constituents from Cornaceae family [9].

The investigation on phytochemical analysis of Davidia involucrata could be traced back to 1982. Haddock and coworkers isolated two phenolic esters from the leaves of Davidia involucrata (dove tree) [10]. One of the phenolic esters was firstly named as davidiin [11] in 1990 by the same group. In the middle of the 1990s, davidiin was found to selectively inhibit the binding of a ligand to a μ-opioid receptor by Zhu et al. [12]. Since then, the antitumor activity of davidiin has been well elucidated by several research groups [13–15]. However, due to the scarcity of Davidia involucrata, little has been done [16] to develop the phytochemical research of the monotypic genus of Davidia. The important bioactivities and structural complexity coupled with the interesting chemical diversity prompted Ouyang to initiate the phytochemical investigations of this genus in 2002. Owing to their continuing efforts, 15 novel compounds combined with 35 known compounds have been isolated and characterized, comprising more than 80% of the reports in this field. Moreover, biological evaluations have been carried out and compounds exhibiting cytotoxicities have been picked out for further investigations. Given the fact that no extensive review in the field has been published, herein, the metabolites from Davidia involucrata that have been documented in the literature from 1982 to 2014 were summarized, concerning the isolation, structural elucidation, and biological evaluation. In fact, every endeavor was made to thoroughly search the literature. Compounds that have novel carbon skeletons and/or biological activities will be discussed in greater detail.

2. Chemical Structures and Biological Activities

Different kinds of secondary metabolites had been isolated from Davidia involucrata. For clarity, they would be introduced sequentially according to their structural features.

2.1. Triterpenoids

2.1.1. Taraxerane-Type and Ursane-Type Triterpenoids

The carbon skeletons of taraxerane triterpene (1) and ursane triterpene (2) have been presented as follows (Figure 2).

The first reported example of triterpenoids from Davidia involucrata was taraxerone 3 and taraxerol 4 isolated by Xiang and Lu [16] in 1989, although 3 and 4 were not new at the time of publication [17, 18]. 3 and 4 were isolated from the petroleum ether fraction of the branch of Davidia involucrata. They were characterized by IR and NMR spectra.

A number of oxygenation patterns around a basic taraxerane skeleton were observed (Figure 3). The dihydroxylated compound myricadiol (5) was isolated from the methanolic extract of the branch bark of Davidia involucrata [19] and the compound had been reported before [20–22]. Taraxerane-type triterpenoids containing carbonyl moieties at positions 3, 16, and 21 of the taraxerane-type skeleton are observed, such as davinvolunone B (6) and davinvolunone C (7). Both of these compounds, which were highly oxidized, were isolated from the same sample of Davidia involucrata and unequivocally determined by extensive spectroscopic analysis [19].

Oxidation of the methyl group at C-28 in the ursane-type skeleton is also observed. Methanolic extraction of the branch bark of Davidia involucrata yielded six examples euscaphic acid (8) [23], myrianthic acid (9) [24], 3β-O-trans-p-coumaroyl-2α-hydroxy-urs-12-en-28-oic acid (10) [25–27], 3β-O-cis-p-coumaroyl-2α-hydroxy-urs-12-en-28-oic acid (11), 3β-O-trans-p-feruloyl-2α-hydroxy-urs-12-en-28-oic acid (12), and 3β-O-cis-p-feruloyl-2α-hydroxy-urs-12-en-28-oic acid (13) [27] where C-28 had been oxidized to a carboxylic acid functionality [19, 28]. Compounds 8–13, which had been previously documented, were characterized by comparison of various spectra including NMR, IR, mass, and specific rotation. Compounds 5–13 were subjected to evaluation for cytotoxic activities against SGC-7901 human gastric cancer cells, MCF-7 human breast cancer cells, and BEL-7404 human hepatoma cells (Table 1). Gratifyingly, compounds 6-7, 10, and 12 showed moderate cytotoxic activities against all the three cell lines [19].

2.1.2. Rearranged Taraxerane-Type and Ursane-Type Triterpenoids

Triterpenes may rearrange to form a 2-nor-pentacyclic triterpenoid carbon skeleton with 29 carbons and a five-membered A-ring, which was unprecedented to the best of one’s knowledge [19, 28]. A plausible biosynthetic pathway was proposed and depicted in Scheme 1. Epoxidation followed by epoxide opening led to the dihydroxylation of the ursane framework. Further oxidative cleavage gave the ring opening product, 2,3-seco-ursane triterpene. Five-member A-ring was generated by ring-contraction rearrangement followed by decarboxylation of the C-3 carboxylic acid moiety (resulting from the selective oxidation of aldehyde functionality).

One example of ring-A modified ursane-type triterpene was davinvolunic acid C (14), a tetracyclic triterpenoid isolated from the methanolic fraction of the branch bark of Davidia involucrata. A rearranged skeleton with a five-member A-ring was also secured from the same source, for example, davinvolunic acid A (15) and davinvolunic acid B (16). The structures of davinvolunic acids A–C were established via exhaustive 1D and 2D NMR spectroscopy. It was noted that davinvolunic acid C (14) showed moderate cytotoxicities against the cell proliferation of SGC-7901, MCF-7, and BEL-7404 with IC₅₀ ranging from 36.3 to 76.4 μM (Table 1) [28].

Davinvolunol A (17), davinvolunol B (18), and davinvolunone A (19) were identified from the water insoluble fraction of the branch bark of Davidia involucrata [19]. Davinvolunone A (19) exhibited moderate cytotoxicities against human tumor cell lines (Table 1). Their carbon skeleton connection and stereochemistry were established through extensive spectral analysis. Interestingly, they all possessed a 5/6/6/6/6 nortriterpenoid framework rearranged from taraxerane-type triterpene (Figure 4). It is postulated that the biosynthetic route of 17–19 was very similar to the pathway presented in Scheme 1.

2.1.3. Lupane-Type Triterpenoids

The third collection of pentacyclic triterpenoids from the MeOH fraction of the branch bark of Davidia involucrata are the lupane-type compounds, including lupeol (20) [29], betulin (21) [30], betulinic acid (22) [31], and platanic acid (23) [32] (Figure 5). The four compounds were not new; however, they exhibited moderate cytotoxic activities against three tumor cell lines (Table 1) [28]. It is noteworthy that betulinic acid (22) not only possessed the most potent antitumor cytotoxicity with IC₅₀ value of 7.26–12.37 μM, but also shows antitumor activity against a broad panel of cancers. In addition, betulinic acid (22) is also found to exhibit antimalarial, antimicrobial, and anti-HIV bioactivities by several research groups [33–36].

2.2. Tannins

2.2.1. Ellagic Acid

3′-O-Methyl-3,4-O,O-methylidene ellagic acid (24), 3,3′,4-5-trimethylellagic acid (25), and ellagic acid (26) were firstly obtained from the ethanolic extraction of the branch of Davidia involucrata by Xiang and Lu [16] in 1989 (Figure 6). The structures were not novel and characterized by comparison of IR and NMR spectra [37–39].

2.2.2. Ellagitannins

Ellagitannins are a structurally and biologically diverse class of hydrolysable tannins [40]. Haddock [10] and coworkers conducted the pioneer work of phytochemical investigation of Davidia involucrata. The first reported examples were β-1,6-(S)-hexahydroxydiphenoyl-2,4-dehydrohexahydroxy-diphenoyl-D-glucopyranose (27) and davidiin (28) from the phenolic extract of the leaves of Davidia involucrata (Figure 6). The relative configurations of 27 and 28 were determined by NMR spectroscopy and the axial chiralities of 27 and 28 were established through circular dichroism spectrum. Recently, a total synthesis of davidiin (27) has been published by Kasai et al. [41] and the chemical structure of davidiin (28) was further confirmed. Davidiin (28) showed anticancer activity against hepatocellular carcinoma cells and DU-145 cells by Chen and Ito [14, 15]. It is noteworthy that davidiin (28) is the strongest nature-derived small ubiquitin-related modification inhibitor reported so far (IC₅₀ value 0.15 μM) [15], which is very promising for drug discovery.

2.3. Phenolic Compounds

2.3.1. Caffeoyl Derivatives

Ouyang’s group also conducted the phytochemical investigation of the leaves of Davidia involucrata. The methanolic extract yielded three novel caffeoyl galactoic acid derivatives, davidiosides A–C (29–31) [42], and the chemical structures of 29–39 were determined by spectroscopic data and chemical evidence. No biological activities were reported for any of the metabolites (Figure 7).

Four known caffeoyl derivatives, such as caffeic acid (32), methyl caffeate (33), chlorogenic acid (34), and methyl chlorogenate (35) [43], were obtained from the same source and characterized by comparison of NMR and mass spectra (Figure 7).

2.3.2. Miscellaneous Phenolic Compounds

The phytochemical research on the methanolic extract of the branch bark of Davidia involucrata also led to the discovery of two new phenolic water-soluble metabolites, involcranoside A (36) and involcranoside B (37) [44] (Figure 7). Identification of their structures was achieved by 1D and 2D NMR experiments. Little is known about their bioactivity profiles.

Five known phenolic compounds, 3,4-dimethoxyphenyl-O-β-D-glucopyranoside (38), picein (29) [45], 1,4-dihydroxy-3-methoxy-phenyl-4-O-β-D-glucopyranoside (40) [46], leonuriside A (41) [47], and 4-hydroxy-3-methoxybenzoic acid (42), were identified along with the two new phenolic glycosides (36-37) and NMR experiments and mass spectroscopy were utilized to secure the structures of 38–42 (Figure 7).

2.4. Neolignans and Lignans

Two new neolignan glycosides, davidioside A (43) and davidioside B (44) [48], were isolated from the methanolic extraction of the branch bark of Davidia involucrata (Figure 8) and identified by 1D and 2D NMR experiments.

In addition, six known compounds, such as dihydrodehydrodiconiferyl alcohol-9-O-β-D-xylopyranoside (45) [49], dihydrodehydrodiconiferyl alcohol-4′-O-β-D-glucopyranoside (46) [50], dihydrodehydrodiconiferyl alcohol-9-O-β-D-glucopyranoside (47) [51], glochidioboside (48) [52], dihydrodehydrodiconiferyl alcohol (49) [53], and isolariciresinol-9-O-β-D-glucopyranoside (50) [54], were coisolated and characterized by comparison of NMR spectroscopy and mass spectral data (Figure 8).

2.5. Flavonoids

Six known flavones and their glycosides were isolated from the methanolic extraction of the leaves of Davidia involucrata [55] (Figure 9). Their structures were established as kaempferol (51), kaempferol-3-O-β-D-glucopyranoside (52), kaempferol-3-O-β-D-galactopyranoside (53), quercetin (54), quercetin-3-O-β-D-arabinopyranoside (55), and quercetin-3-O-β-D-galactopyranoside (56) [56]. The structures of all these compounds were identified by comparison of the spectra data.

The isolated tannins, phenolic compounds, lignans, and flavonoids demonstrated the potential to serve as radical scavengers and antioxidant reagents in light of their structural features [57–62].

2.6. Alkaloid Glycosides

Three known compounds (Figure 10), one quinoline alkaloid glycoside pumiloside (57) [63] and two closely related indole alkaloid glycosides vincosamide (58) [64] and strictosidinic acid (59) [65], were isolated from the MeOH extract of the branch bark of Davidia involucrata and determined through careful analysis of the spectroscopic data [66, 67]. It is noted that the structure of pumiloside (57) is similar to camptothecin [68–70], a remarkable anticancer lead compound. In fact, pumiloside (57) serves as a biosynthetic precursor of camptothecin [71].

Chemical transformations were performed to hydrolyze compounds 36–59. The sugars were verified by comparison with authentic samples to provide chemical evidences.

2.7. Sterol

β-Sitosterol (60) is the only compound in this group (Figure 10). Although it existed as a widely distributed known plant sterol [72], β-sitosterol was firstly reported to be isolated from the petroleum ether extract of the branch of Davidia involucrata and identified by spectroscopic analysis by Xiang and Lu [16] in 1989.

3. Conclusions

A literature review of constituents from Davidia involucrata has been done and several conclusions could be drawn. Firstly, the new and unique structures isolated reflect the chemical diversity of Davidia involucrata. The novel phytochemistry presented in this review provides important evolutionary and chemotaxonomic knowledge of the monotypic genus Davidia. Secondly, these compounds constitute an interesting type of natural products, for some of them, as davidiin, have shown important biological activities. However, the bioactivity profiles of many of them are still not fully demonstrated. Finally, Davidia involucrata is one of the least studied groups of plants and therefore represents great potential for the discovery of new pharmacologically active metabolites.

Competing Interests

The authors declare no conflict of interests.

Acknowledgments

Financial support from National Natural Science Foundation of China (Grant no. 21502018), Fujian Provincial Department of Science and Technology Major Project (Grant nos. K53150006 and K1312004), Natural Science Foundation of Fujian Province (Grant no. 2016J05024), Fujian Provincial Department of Education (Grant no. JA15148), and Outstanding Young Scholars of Fujian Agriculture and Forestry University (Grant no. xjq201623) is gratefully acknowledged.

References

J. S. He, H. Lin, and W. L. Chen, “Actuality and protection of the Chinese peculiar plant Davidia involucrata,” Chinese Biodiversity, vol. 3, pp. 213–221, 1995.
View at: Google Scholar
J. Hu, Z. Su, and Y. Li, “Research advance on dovetree biology,” Chinese Wild Plant Resources, vol. 22, pp. 15–19, 2003.
View at: Google Scholar
L. J. Zhu, Z. X. Su, J. Y. Hu, R. J. Su, and L. Zhou, “Studies on the relationship of species in Davidia involucrata community,” Guihaia, vol. 26, pp. 32–37, 2006.
View at: Google Scholar
J. Zhang, J. Li, B. Zhou, and X. Lian, “Natural distribution of Davidia involucrata and introduction analysis,” Journal of Beijing Forestry University, vol. 17, pp. 25–30, 1995.
View at: Google Scholar
Y.-X. Li, L. Chen, L. Juan, Y. Li, and F. Chen, “Suppression subtractive hybridization cloning of cDNAs of differentially expressed genes in dovetree (Davidia involucrata) bracts,” Plant Molecular Biology Reporter, vol. 20, no. 3, pp. 231–238, 2002.
View at: Publisher Site | Google Scholar
Z.-C. He, J.-Q. Li, and H.-C. Wang, “Karyomorphology of Davidia involucrata and Camptotheca acuminata, with special reference to their systematic positions,” Botanical Journal of the Linnean Society, vol. 144, no. 2, pp. 193–198, 2004.
View at: Publisher Site | Google Scholar
J.-F. Sun, Y.-B. Gong, S. S. Renner, and S.-Q. Huang, “Multifunctional bracts in the dove tree Davidia involucrata (Nyssaceae: Cornales): rain protection and pollinator attraction,” The American Naturalist, vol. 171, no. 1, pp. 119–124, 2008.
View at: Publisher Site | Google Scholar
M. E. Wall, M. C. Wani, C. E. Cook, K. H. Palmer, A. T. McPhail, and G. A. Sim, “Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata,” Journal of the American Chemical Society, vol. 88, no. 16, pp. 3888–3890, 1966.
View at: Publisher Site | Google Scholar
J. Huang, R. Liu, C. Z. Wang, and M. A. Ouyang, “Progress in chemical constituents of Nyssaceae family,” Subtropical Plant Science, vol. 34, no. 2, pp. 70–75, 2005.
View at: Google Scholar
E. A. Haddock, R. K. Gupta, and E. Haslam, “The metabolism of gallic acid and hexahydroxydiphenic acid in plants. Part 3. Esters of (R)- and (S)-hexahydroxydiphenic acid and dehydrohexahydroxydiphonic acid with D-glucopyranose (¹C₄ and related conformations),” Journal of the Chemical Society, Perkin Transaction, vol. 1, pp. 2535–2545, 1982.
View at: Google Scholar
C. M. Spencer, Y. Cai, R. Martin, T. H. Lilley, and E. Haslam, “The metabolism of gallic acid and hexahydroxydiophenic acid in higher plants part 4; polyphenol interactions part 3. Spectroscopic and physical properties of esters of gallic acid and (S)-hexahydroxydiphenic acid with D-glucopyranose (⁴C₁),” Journal of the Chemical Society, Perkin Transactions 2, no. 4, pp. 651–660, 1990.
View at: Google Scholar
M. Zhu, J. D. Phillipson, P. M. Greengrass, N. E. Bowery, and Y. Cai, “Plant polyphenols: biologically active compounds or non-selective binders to protein?” Phytochemistry, vol. 44, no. 3, pp. 441–447, 1997.
View at: Publisher Site | Google Scholar
J. Fu, J.-Y. Ma, X.-F. Zhang et al., “Identification of metabolites of FR429, a potential antitumor ellagitannin, transformed by rat intestinal bacteria in vitro, based on liquid chromatography-ion trap-time of flight mass spectrometry analysis,” Journal of Pharmaceutical and Biomedical Analysis, vol. 71, pp. 162–167, 2012.
View at: Publisher Site | Google Scholar
Y. Wang, J. Ma, S. C. Chow et al., “A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2,” Tumor Biology, vol. 35, no. 1, pp. 205–212, 2014.
View at: Publisher Site | Google Scholar
M. Takemoto, Y. Kawamura, M. Hirohama et al., “Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata,” Journal of Antibiotics, vol. 67, no. 4, pp. 335–338, 2014.
View at: Publisher Site | Google Scholar
G. Q. Xiang and F. S. Lu, “Study on chemical components of Davidia involucrata Baill. native to China,” Acta Botanica Sinica, vol. 31, no. 7, pp. 540–543, 1989.
View at: Google Scholar
R. E. Corbett, S. D. Cumming, and E. V. Whitehead, “Lichens and fungi. Part X. 14α-taraxerane,” Journal of the Chemical Society, Perkin Transactions 1, pp. 2827–2829, 1972.
View at: Publisher Site | Google Scholar
A. S. R. Anjaneyulu, L. R. Row, C. Subrahmanyam, and K. S. Murty, “Crystalline constituents of Euphorbiaceae Part XIV. Isolation of epitaraxerol from Euphorbia royleana Boiss,” Current Science, vol. 43, no. 1, pp. 10–11, 1974.
View at: Google Scholar
Q.-W. Tan, M.-A. Ouyang, Q.-J. Chen, and Z.-J. Wu, “Five new taraxerene-type triterpenes from the branch barks of Davidia involucrata,” Molecules, vol. 19, no. 11, pp. 17619–17631, 2014.
View at: Publisher Site | Google Scholar
P. G. Kerr, R. B. Longmore, and T. J. Betts, “Myricadiol and other taraxerenes from Scaevola spinescens,” Planta Medica, vol. 62, no. 6, pp. 519–522, 1996.
View at: Publisher Site | Google Scholar
I. Merfort, J. Buddrus, M. A. M. Nawwar, and J. Lambert, “A triterpene from the bark of Tamarix aphylla,” Phytochemistry, vol. 31, no. 11, pp. 4031–4032, 1992.
View at: Publisher Site | Google Scholar
N. Sakurai, Y. Yaguchi, and T. Inoue, “Triterpenoids from Myrica rubra,” Phytochemistry, vol. 26, no. 1, pp. 217–219, 1986.
View at: Publisher Site | Google Scholar
G.-Y. Liang, A. I. Gray, and P. G. Waterman, “Pentacyclic triterpenes from the fruits of Rosa sterilis,” Journal of Natural Products, vol. 52, no. 1, pp. 162–166, 1989.
View at: Publisher Site | Google Scholar
J. Wandji, F. Tillequin, D. A. Mulholland et al., “Pentacyclic triterpenoid and saponins from Gambeya boukokoensis,” Phytochemistry, vol. 64, no. 4, pp. 845–849, 2003.
View at: Publisher Site | Google Scholar
M. Ogura, G. A. Cordell, and N. R. Farnsworth, “Jacoumaric acid, a new triterpene ester from Jacaranda caucana,” Phytochemistry, vol. 16, no. 2, pp. 286–287, 1977.
View at: Publisher Site | Google Scholar
Q. Wang, J. U. Peng, Y. F. Wang, and S. D. Luo, “Triterpenoids from Saurauia napaulensis (Saurauiaceae),” Acta Botanica Yunnanica, vol. 30, pp. 121–124, 2008.
View at: Google Scholar
H. Häberlein and K.-P. Tschiersch, “Triterpenoids and flavonoids from Leptospermum scoparium,” Phytochemistry, vol. 35, no. 3, pp. 765–768, 1994.
View at: Publisher Site | Google Scholar
Q.-W. Tan, M.-A. Ouyang, and B. Gao, “Three new ring-a modified ursane triterpenes from Davidia involucrata,” Molecules, vol. 19, no. 4, pp. 4897–4906, 2014.
View at: Publisher Site | Google Scholar
J. Fotie, D. S. Bohle, M. L. Leimanis, E. Georges, G. Rukunga, and A. E. Nkengfack, “Lupeol long-chain fatty acid esters with antimalarial activity from Holarrhena floribunda,” Journal of Natural Products, vol. 69, no. 1, pp. 62–67, 2006.
View at: Publisher Site | Google Scholar
M. M. O'Connell, M. D. Bentley, C. S. Campbell, and B. J. W. Cole, “Betulin and lupeol in bark from four white-barked birches,” Phytochemistry, vol. 27, no. 7, pp. 2175–2176, 1988.
View at: Publisher Site | Google Scholar
D. Z. L. Bastos, I. C. Pimentel, D. A. de Jesus, and B. H. de Oliveira, “Biotransformation of betulinic and betulonic acids by fungi,” Phytochemistry, vol. 68, no. 6, pp. 834–839, 2007.
View at: Publisher Site | Google Scholar
T. Fujioka, Y. Kashiwada, R. E. Kilkuskie et al., “Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids,” Journal of Natural Products, vol. 57, no. 2, pp. 243–247, 1994.
View at: Publisher Site | Google Scholar
H. Kommera, G. N. Kaluđerović, J. Kalbitz, and R. Paschke, “Lupane Triterpenoids-Betulin and Betulinic acid derivatives induce apoptosis in tumor cells,” Investigational New Drugs, vol. 29, no. 2, pp. 266–272, 2011.
View at: Publisher Site | Google Scholar
J. H. Kessler, F. B. Mullauer, G. M. de Roo, and J. P. Medema, “Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types,” Cancer Letters, vol. 251, no. 1, pp. 132–145, 2007.
View at: Publisher Site | Google Scholar
F. B. Mullauer, J. H. Kessler, and J. P. Medema, “Betulinic acid, a natural compound with potent anticancer effects,” Anti-Cancer Drugs, vol. 21, no. 3, pp. 215–227, 2010.
View at: Publisher Site | Google Scholar
F. B. Mullauer, J. H. Kessler, and J. P. Medema, “Betulin is a potent anti-tumor agent that is enhanced-by cholesterol,” PLoS ONE, vol. 4, no. 4, pp. 5361–5368, 2009.
View at: Publisher Site | Google Scholar
L. T. Lin, T. Y. Chao, and J. S. Hsu, “Chemical constituents of the anticancer plant Camptotheca acuminata decne. I. Chemical constituents of the roots of Camptotheca acuminata decne,” Acta Chimica Sinica, vol. 35, no. 3, pp. 227–231, 1977.
View at: Google Scholar
L. Z. Lin, C. Q. Song, and R. S. Xu, “Chemical constituents of the anticancer plant Camptotheca acuminata decne. III. Ellagic acids from the fruits of Camptotheca acuminata decne,” Acta Chimica Sinica, vol. 37, no. 3, pp. 207–214, 1979.
View at: Google Scholar
D. B. Corrêa, E. Birchal, J. E. V. Aguilar, and O. R. Gottlieb, “Ellagic acids from vochysiaceae,” Phytochemistry, vol. 14, no. 4, pp. 1138–1139, 1975.
View at: Publisher Site | Google Scholar
J. M. Landete, “Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health,” Food Research International, vol. 44, no. 5, pp. 1150–1160, 2011.
View at: Publisher Site | Google Scholar
Y. Kasai, N. Michihata, H. Nishimura, T. Hirokane, and H. Yamada, “Total synthesis of (+)-davidiin,” Angewandte Chemie—International Edition, vol. 51, no. 32, pp. 8026–8029, 2012.
View at: Publisher Site | Google Scholar
M.-A. Ouyang, J.-N. Zhou, and S.-B. Wang, “New caffeoyl derivatives from the leaves of Davidia involucrata,” Natural Product Research, vol. 22, no. 6, pp. 471–476, 2008.
View at: Publisher Site | Google Scholar
C. Yang, J.-G. Shi, S.-Y. Mo, and Y.-C. Yang, “Chemical constituents of Pyrrosia petiolosa,” Journal of Asian Natural Products Research, vol. 5, no. 2, pp. 143–150, 2003.
View at: Publisher Site | Google Scholar
Z.-J. Wu, M.-A. Ouyang, and S.-B. Wang, “Two new phenolic water-soluble constituents from branch bark of Davidia involucrata,” Natural Product Research, vol. 22, no. 6, pp. 483–488, 2008.
View at: Publisher Site | Google Scholar
M. Ushiyama and T. Furuya, “Glycosylation of phenolic compounds by root culture of Panax ginseng,” Phytochemistry, vol. 28, no. 11, pp. 3009–3013, 1989.
View at: Publisher Site | Google Scholar
H. Pan and L. N. Lundgren, “Phenolic extractives from root bark of Picea abies,” Phytochemistry, vol. 39, no. 6, pp. 1423–1428, 1995.
View at: Publisher Site | Google Scholar
H. Otsuka, M. Takeuchi, S. Inoshiri, T. Sato, and K. Yamasaki, “Phenolic compounds from Coix lachryma-jobi var. Ma-yuen,” Phytochemistry, vol. 28, no. 3, pp. 883–886, 1989.
View at: Publisher Site | Google Scholar
M.-A. Ouyang, J. Huang, and Q.-W. Tan, “Neolignan and lignan glycosides from branch bark of Davidia involucrata,” Journal of Asian Natural Products Research, vol. 9, no. 6, pp. 487–492, 2007.
View at: Publisher Site | Google Scholar
I. Kouno, Y. Yanagida, S. Shimono, M. Shintomi, Y. Ito, and Y. Chun-Shu, “Neolignans and a phenylpropanoid glucoside from Illicium difengpi,” Phytochemistry, vol. 32, no. 6, pp. 1573–1577, 1993.
View at: Publisher Site | Google Scholar
C. Kraus and G. Spiteller, “Comparison of phenolic compounds from galls and shoots of Picea glauca,” Phytochemistry, vol. 44, no. 1, pp. 59–67, 1997.
View at: Publisher Site | Google Scholar
C. Wang and Z. Jia, “Lignan, phenylpropanoid and iridold glycosides from Pedicularis torta,” Phytochemistry, vol. 45, no. 1, pp. 159–166, 1997.
View at: Publisher Site | Google Scholar
Y. Takeda, C. Mima, T. Masuda, E. Hirata, A. Takushi, and H. Otsuka, “Glochidioboside, a glucoside of (7S,8R)-dihydrodehydrodiconiferyl alcohol from leaves of Glochidion obovatum,” Phytochemistry, vol. 49, no. 7, pp. 2137–2139, 1998.
View at: Publisher Site | Google Scholar
L. A. C. Pieters, D. A. V. Berghe, and A. J. Vlietinck, “A dihydrobenzofuran lignan from Croton erythrochilus,” Phytochemistry, vol. 29, no. 1, pp. 348–349, 1990.
View at: Publisher Site | Google Scholar
K. Yuasa, T. Ide, H. Otsuka et al., “Lignan and neolignan glycosides from stems of Alangium premnifolium,” Phytochemistry, vol. 45, no. 3, pp. 611–615, 1997.
View at: Publisher Site | Google Scholar
M. A. Ouyang and J. N. Zhou, “Flavonoid glycosides from the leaves of Davidia involucrata,” Guihaia, vol. 23, no. 6, pp. 568–570, 2003.
View at: Google Scholar
K. R. Markham, B. Ternai, R. Stanley, H. Geiger, and T. J. Mabry, “Carbon-13 NMR studies of flavonoids—III: naturally occurring flavonoid glycosides and their acylated derivatives,” Tetrahedron, vol. 34, no. 9, pp. 1389–1397, 1978.
View at: Publisher Site | Google Scholar
C. A. Rice-Evans, N. J. Miller, and G. Paganga, “Antioxidant properties of phenolic compounds,” Trends in Plant Science, vol. 2, no. 4, pp. 152–159, 1997.
View at: Publisher Site | Google Scholar
C. A. Rice-Evans, N. J. Miller, and G. Paganga, “Structure-antioxidant activity relationships of flavonoids and phenolic acids,” Free Radical Biology and Medicine, vol. 20, no. 7, pp. 933–956, 1996.
View at: Publisher Site | Google Scholar
K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, “Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships,” Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572–584, 2002.
View at: Publisher Site | Google Scholar
B. Fauconneau, P. Waffo-Teguo, F. Huguet, L. Barrier, A. Decendit, and J.-M. Merillon, “Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests,” Life Sciences, vol. 61, no. 21, pp. 2103–2110, 1997.
View at: Publisher Site | Google Scholar
H. Lu and G.-T. Liu, “Anti-oxidant activity of dibenzocyclooctene lignans isolated from Schisandraceae,” Planta Medica, vol. 58, no. 4, pp. 311–313, 1992.
View at: Publisher Site | Google Scholar
D. D. Kitts, Y. V. Yuan, A. N. Wijewickreme, and L. U. Thompson, “Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone,” Molecular & Cellular Biochemistry, vol. 202, no. 1-2, pp. 91–100, 1999.
View at: Publisher Site | Google Scholar
Z. Zhang, H. N. ElSohly, M. R. Jacob, D. S. Pasco, L. A. Walker, and A. M. Clark, “New indole alkaloids from the bark of Nauclea orientalis,” Journal of Natural Products, vol. 64, no. 8, pp. 1001–1005, 2001.
View at: Publisher Site | Google Scholar
A. Itoh, T. Tanahashi, and N. Nagakura, “Five tetrahydroisoquinoline-monoterpene glucosides and a tetrahydro-β-carboline-monoterpene glucoside from Alangium lamarckii,” Journal of Natural Products, vol. 58, no. 8, pp. 1228–1239, 1995.
View at: Publisher Site | Google Scholar
M. Kitajima, K. Hashimoto, M. Yokoya, H. Takayama, N. Aimi, and S. Sakai, “A new glucoindole alkaloid, 3,4-dehydro-5-carboxystrictosidine, form Peruvian Uña de Gato (Uncariatomentosa),” Chemical & Pharmaceutical Bulletin, vol. 48, no. 10, pp. 1410–1412, 2000.
View at: Google Scholar
R. Liu and M. A. Ouyang, “Structural identification of pumiloside, a quinolone alkaloid glycoside isolated from leaves of Davidia involucrata,” Subtropical Plant Science, vol. 35, no. 1, pp. 35–38, 2006.
View at: Google Scholar
R. Liu, C. Z. Wang, and M. A. Ouyang, “Studies on the alkaloid glycoside constituents from branch bark of Davidia involucrata,” Guihaia, vol. 27, no. 2, pp. 277–280, 2007.
View at: Google Scholar
T. R. Govindachari and N. Viswanathan, “Alkaloids of Mappia foetida,” Phytochemistry, vol. 11, no. 12, pp. 3529–3531, 1972.
View at: Publisher Site | Google Scholar
T. Efferth, Y.-J. Fu, Y.-G. Zu, G. Schwarz, V. S. B. Konkimalla, and M. Wink, “Molecular target-guided tumour therapy with natural products derived from traditional Chinese Medicine,” Current Medicinal Chemistry, vol. 14, no. 19, pp. 2024–2032, 2007.
View at: Publisher Site | Google Scholar
S. Sirikantaramas, T. Asano, H. Sudo, M. Yamazaki, and K. Saito, “Camptothecin: therapeutic potential and biotechnology,” Current Pharmaceutical Biotechnology, vol. 8, no. 4, pp. 196–202, 2007.
View at: Publisher Site | Google Scholar
N. Aimi, M. Nishimura, A. Miwa, H. Hoshino, S.-I. Sakai, and J. Haginiwa, “Pumiloside and deoxypumiloside; plausible intermediates of camptothecin biosynthesis,” Tetrahedron Letters, vol. 30, no. 37, pp. 4991–4994, 1989.
View at: Publisher Site | Google Scholar
O. Rosenheim and T. A. Webster, “The metabolism of β-sitosterol,” Biochemical Journal, vol. 35, no. 8-9, pp. 928–931, 1941.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2016 Li-Yan Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1493

Downloads

946

Citations